Draegerwerk AG KGaA (HAM:DRW8) Research & Development: €330 Mil (TTM As of Mar. 2026)


HAM:DRW8 Draegerwerk AG & Co KGaA HAM:DRW8
75 GF Score
Price €70.20
GF Value €47.88
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Draegerwerk AG KGaA Research & Development?

Draegerwerk AG KGaA HAM:DRW8 75 Research & Development is €330 Mil as of Mar. 2026. GuruFocus rates HAM:DRW8 with a GF Score™ of 75/100 and a GF Value™ of €47.88 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Draegerwerk AG KGaA's Research & Development for the three months ended in Mar. 2026 was €80 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €330 Mil.

Draegerwerk AG KGaA  (HAM:DRW8) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Draegerwerk AG KGaA Research & Development Related Terms

Draegerwerk AG KGaA Research & Development Historical Data

* Premium members only.

The historical data trend for Draegerwerk AG KGaA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Draegerwerk AG KGaA Research & Development Chart

Draegerwerk AG KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 328.58 343.48 325.36 333.07 333.82

Draegerwerk AG KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.57 85.95 79.64 84.67 79.84
HAM:DRW8
75GF Score
Draegerwerk AG & Co KGaA HAM:DRW8
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Draegerwerk AG KGaA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €330 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €330 Mil mean?
Draegerwerk AG KGaA (HAM:DRW8) has a Research & Development of €330 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Draegerwerk AG KGaA and its competitors.
Is Draegerwerk AG KGaA's Research & Development too high?
Draegerwerk AG KGaA's current Research & Development is €330 Mil. Overall, Draegerwerk AG KGaA has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's Research & Development compare to ABT and SYK?
Draegerwerk AG KGaA's Research & Development of €330 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Draegerwerk AG KGaA and its competitors. Draegerwerk AG KGaA's current Research & Development is €330 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (HAM:DRW8) is currently considered Significantly Overvalued. The stock's GF Value™ is €47.88, compared to a current price of €70.20 — trading 46.6% above its estimated fair value. The current Research & Development is €330 Mil. Draegerwerk AG KGaA's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Draegerwerk AG KGaA (HAM:DRW8), the current Research & Development is €330 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Draegerwerk AG KGaA (HAM:DRW8) Overvalued in 2026?

Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued. The current stock price of €70.20 is trading 46.6% above its estimated GF Value™ of €47.88. GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.

Key valuation signals for HAM:DRW8:

  • Research & Development: €330 Mil
  • GF Value™: €47.88 vs. price of €70.20 (46.6% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the HAM:DRW8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Draegerwerk AG KGaA Business Description

Address Moislinger Allee 53 - 55, Lubeck, DEU, 23542
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
75GF Score

Get the complete analysis for HAM:DRW8

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.20
Price
€47.88
GF Value